** Shares in Tecan TECN.S fall 5.4% after the laboratory instruments provider maintained its mid-term outlook and posted its Q3 results
** The weak reaction is "in light of the confirmed specified sales guidance," analysts at UBS say
** UBS adds that the guidance implies mid-single-digit downside to current 2025 EPS consensus estimates
** Vontobel analysts see 2025 and now also 2026 as transitional years, adding that sentiment on the stock remains mixed
** Shares undeperform pan-European .STOXX, which is up 0.4%
(Reporting by Paolo Laudani)
((Paolo.laudani@thomsonreuters.com))